Katarzyna Jakuszkowiak-Wojten

Katarzyna Jakuszkowiak-Wojten

Auto-generated profile, based on publicly available information

Katarzyna Jakuszkowiak-Wojten

Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, 80-952 Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
MHMarta Herstowska
Marta Herstowska
OKOlivia Komorowska
Olivia Komorowska
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała
KJKatarzyna Jakuszkowiak-Wojten
Katarzyna Jakuszkowiak-Wojten
MGMaria Gałuszko-Węgielnik
Maria Gałuszko-Węgielnik
JLJerzy Landowski
Jerzy Landowski
Clinical manifestations of drug-induced skin reactions include a wide range of symptoms, from mild drug-induced exanthemas to dangerous and life-threatening generalized systematic reactions. Adverse drug reactions of low risk include phenomena such as drug-induced rashes, phototoxic reactions,...

12 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
AWAlina Wilkowska
Alina Wilkowska
MWMariusz Wiglusz
Mariusz Wiglusz
KJKatarzyna Jakuszkowiak-Wojten
Katarzyna Jakuszkowiak-Wojten
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała
Background and Objectives: Ketamine is a rapid-acting antidepressant with proven efficacy as an add-on agent in unipolar and bipolar treatment-resistant depression. Although many studies have been published, there is still not enough data on the effect of ketamine in combination with other medications. Particularly interesting is the combination of ketamine and lamotrigine, and its potential role in bipolar depression. The aim of this review was to identify animal and human studies in which ketamine and lamotrigine were used together in order to find out if there is scientific ground for combining ketamine and lamotrigine in the treatment of mood disorders. Directions for future studies are presented. Materials and Methods: PubMed and Web of Science were searched. Preferred Reporting Items for Systematic Reviews and Meta-Analyses PRISMA 2020 methodology was applied. Results: Seventeen studies were included for review. Animal studies using models of depression suggested a synergistic effect of ketamine and lamotrigine in combination. Studies on healthy humans showed a reduction in ketamine-induced dissociative symptoms with lamotrigine pretreatment. In a study on patients with depression, ketamine and lamotrigine did not have a stronger antidepressant effect than ketamine alone, but in this study only one ketamine infusion was administered. One case series described the antidepressant and anti-suicidal effect of the combination in two bipolar patients. Available clinical studies on patients with mood disorders did not support the hypothesis that lamotrigine reduces ketamine-induced dissociative symptoms. Conclusions: The results of the analyzed studies were not sufficient to answer any of the stated questions; however, they allowed us to delineate future research directions. The identified animal studies suggested a possible synergistic antidepressant effect of ketamine and lamotrigine. The available clinical studies were not conclusive. No controlled studies on large groups of bipolar patients with multiple ketamine infusions combined with lamotrigine treatment have been published so far. There is some evidence for the reduction of ketamine’s side effects by lamotrigine, and there are reports suggesting that lamotrigine can reduce ketamine craving. More studies with follow-up are needed in order to investigate the ketamine–lamotrigine combination in bipolar patients.

1 September 2013
Verified
Journal Article
Closed access
MCMonika Czarnowska-Cubała
Monika Czarnowska-Cubała
MWMariusz Wiglusz
Mariusz Wiglusz
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała
KJKatarzyna Jakuszkowiak-Wojten
Katarzyna Jakuszkowiak-Wojten
JLJerzy Landowski
Jerzy Landowski
Krzysztof KrystaKrzysztof Krysta
Krzysztof Krysta

13 January 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MGMaria Gałuszko-Węgielnik
Maria Gałuszko-Węgielnik
ZCZuzanna Chmielewska
Zuzanna Chmielewska
KJKatarzyna Jakuszkowiak-Wojten
Katarzyna Jakuszkowiak-Wojten
MWMariusz Wiglusz
Mariusz Wiglusz
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała
Psychotic treatment-resistant depression is a complex and challenging manifestation of mood disorders in the clinical setting. Psychotic depression is a subtype of major depressive disorder characterized by mood-consistent hallucinations and/or delusions. Psychotic depression is often underdiagnosed and undertreated. Ketamine appears to have rapid and potent antidepressant effects in clinical studies, and the Federal Drug Agency approved the use of ketamine enantiomer esketamine-nasal spray for treatment-resistant depression pharmacotherapy in 2019. This study aimed to assess the usage of ketamine for major depressive disorder with psychotic features as an add-on treatment to the standard of care. Here we present four inpatients suffering from treatment-resistant depression with psychotic features, including one with severe suicidal crisis, all treated with 0.5 mg/kg intravenous infusion of ketamine. Subsequent monitoring revealed no exacerbation of psychotic symptoms in short and long-term observation, while stable remission was observed in all cases with imminent antisuicidal effect. Results suggest ketamine may benefit individuals with treatment-resistant depression with psychotic features.

1 July 2018 in The European Journal of Psychiatry
Verified
Journal Article
Closed access
RMR. Miela
R. Miela
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała
DMDariusz Wojciech Mazurkiewicz
Dariusz Wojciech Mazurkiewicz
KJK. Jakuszkowiak-Wojten
K. Jakuszkowiak-Wojten

1 September 2015
Verified
Journal Article
Closed access
KJKatarzyna Jakuszkowiak-Wojten
Katarzyna Jakuszkowiak-Wojten
JLJerzy Landowski
Jerzy Landowski
MWMariusz Wiglusz
Mariusz Wiglusz
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała